Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 10, 2011 13:47 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Appoints Randy Berholtz as Executive Vice President, General Counsel and Secretary

SAN DIEGO, May 10, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc., ("Apricus Bio") (Nasdaq:APRI) today announced that Randy Berholtz, Esq. has been appointed as the Company's Executive Vice...
May 10, 2011 09:23 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces First Quarter 2011 Financial Results Conference Call

SAN DIEGO, May 10, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) announced today that management will hold a conference call to discuss its first quarter 2011...
May 03, 2011 11:17 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences' Corporate Development Executive Interviewed on Steve Crowley's American Scene

SAN DIEGO, May 3, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc., ("Apricus Bio") (Nasdaq:APRI) today announced that Edward Cox, Vice President, Corporate Development and Investor Relations, was...
April 28, 2011 10:06 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Requests Approval of Vitaros(R) as a Treatment for Erectile Dysfunction in Europe

SAN DIEGO, April 28, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) announced today that it has filed a marketing application in Europe for Vitaros® as a...
April 27, 2011 13:07 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences to Present at the FSX Investor Conference in San Francisco on April 28, 2011

SAN DIEGO, April 27, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences ("Apricus Bio") (Nasdaq:APRI) today announced that Ed Cox, Vice President Corporate Development and Investor Relations, will present...
April 19, 2011 10:34 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Building Strong Pipeline and Solid Financials, CEO, Dr. Bassam Damaj, Tells CEO/CFO Magazine

SAN DIEGO, April 19, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences ("Apricus Bio") (Nasdaq:APRI) (http://www.apricusbio.com/index.html) is building a strong product pipeline backed by a sound financial...
April 13, 2011 13:11 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Files for Orphan Drug Designation for RayVa(TM)

SAN DIEGO, April 13, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) announced today its filing with the U.S. Food & Drug Administration ("FDA") requesting orphan...
April 05, 2011 12:16 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences' CEO Interviewed by WallStreetCorner.com

SAN DIEGO, April 5, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that Chairman, President and Chief Executive Officer,...
March 31, 2011 10:41 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Expands Patent Coverage in Mexico for Its Erectile Dysfunction Drug, Vitaros(R)

SAN DIEGO, March 31, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI), announced today that the Mexican Patent Office ("MPO") will grant an additional patent for...
March 24, 2011 09:53 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Adopts Shareholder Rights Plan

SAN DIEGO, March 24, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) announced today that its Board of Directors (the "Board") has adopted a Shareholder Rights Plan...